Product Overview AOD-9604 is a synthetic peptide research compound widely studied in controlled laboratory environments focused on peptide signalling pathways, molecular communication systems and receptor-mediated biological processes
You can find detailed information on this in the following privacy policy
Alpha-1 microglobulin as a potential therapeutic candidate for treatment of hypertension and oxidative stress in the STOX1 preeclampsia mouse model
Batch: GF-BPCTB10-B241 Key analytical results include: BPC-157 Assay Content: 16.04 mg BPC-157 Identification by RT: 0.993 BPC-157 Purity: greater than 99.8 percent BPC-157 Molecular Ion Mass Identification: 1418 Da TB-500 Assay Content: 13.44 mg TB-500 Identification by RT: 0.999 TB-500 Purity: 99.6 percent TB-500 Molecular Ion Mass Identification: 4962 Da Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Product Overview BPC-157/TB-500 is a dual-peptide research formulation combining two extensively studied peptide compounds within a single laboratory preparation
By now, the studies of Takahasi (Takahasi et al., 1988
Most positive PTs had onset times of less than 50 days (dry skin, alopecia, erythema, night sweats, onychoclasis, pruritus, rash, urticaria, angioedema, and maculopapular rash), suggesting acute impacts on patient quality of life